Skip to main content

Triamterene and Hydrochlorothiazide

NDC 55289-090 · PD-Rx Pharmaceuticals, Inc.

Generic nameTriamterene and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)TRIAMTERENE, HYDROCHLOROTHIAZIDE
Strength25; 37.5 mg/1; mg/1
Pharmacologic classDecreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

55289-090-15 — 15 TABLET in 1 BOTTLE, PLASTIC (55289-090-15)

55289-090-30 — 30 TABLET in 1 BOTTLE, PLASTIC (55289-090-30)

55289-090-90 — 90 TABLET in 1 BOTTLE, PLASTIC (55289-090-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

52817-364 — Triamterene Capsules, 52817-365 — Triamterene Capsules, 53489-144 — Spironolactone and Hydrochlorothiazide, 53746-845 — Valsartan and Hydrochlorothiazide, 53746-846 — Valsartan and Hydrochlorothiazide, 53746-847 — Valsartan and Hydrochlorothiazide, 53746-848 — Valsartan and Hydrochlorothiazide, 53746-849 — Valsartan and Hydrochlorothiazide, 55111-133 — Enalapril maleate and hydrochlorothiazide, 55111-134 — Enalapril maleate and hydrochlorothiazide, 55289-488 — Triamterene and Hydrochlorothiazide, 55700-006 — Hydrochlorothiazide, 57237-002 — Hydrochlorothiazide, 59212-002 — Triamterene, 59212-003 — Triamterene, 59651-678 — Bisoprolol Fumarate and Hydrochlorothiazide, 59651-679 — Bisoprolol Fumarate and Hydrochlorothiazide, 59651-680 — Bisoprolol Fumarate and Hydrochlorothiazide, 59746-337 — losartan potassium and hydrochlorothiazide, 59746-338 — losartan potassium and hydrochlorothiazide, +863 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels